Manchin’s Deal Won’t Save the Democrats in the Midterms

5Mind. The Meme Platform
Wall Street Journal Header

They’ll have to rely on unhinged Republican candidates to hold the Senate in November.

Hope springs eternal, especially among politicians facing an electoral wipeout. Democratic leaders and their media confederates quickly embraced the latest life-preserver: the recent deal between Senate Majority Leader Chuck Schumer and Sen. Joe Manchin (D., W.Va.) to resurrect the Build Back Better Bill.

The two senators slimmed down the legislative monstrosity and restyled it the Inflation Reduction Act. That nonsense label is worthy of a P.T. Barnum ad campaign. The Penn Wharton Budget Model predicts that the bill’s impact on inflation will be “statistically indistinguishable from zero.”

It isn’t clear this slimmer bill can pass, but already the Washington Post has trumpeted the hodgepodge of climate provisions, a three-year extension of ObamaCare subsidies, and price controls on some drugs provided through Medicare as having “the potential to change the narrative” of Joe Biden’s presidency.

Mr. Biden needs all the help he can get: His 38% approval rating in a late July Gallup Poll is down from the 40% average in the sixth quarter of his presidency, itself the lowest figure for any president since Gallup began routinely measuring in the 1950s.

So Democrats are pumping this latest Build Back Better incarnation big time, hoping it’ll be the life raft they need. A White House spokesman says it shows “Democrats have a plan to lower costs for middle class families.” Retiring Illinois Rep. Cheri Bustos claims it gives her party “the Big MO,” while Virginia Rep. Abigail Spanberger proclaimed it will “change people’s lives.”

Such hyperbole won’t save Democrats; voters will see that the promises don’t match reality. Take California Rep. Mike Levin’s claim that the bill “will dramatically reduce costs for the average American that has to pay exorbitant prices for prescription drugs.” These price controls would apply only to expensive drugs with no generic competition offered through Medicare, starting with 10 such drugs in 2026. Consumers won’t feel any cost difference ahead of the midterms.

That’s a major problem for a bill claiming to ease the high prices fueling voter frustration. This $485 billion legislation won’t reduce inflation in the near term and could even make it slightly worse.

Like last year’s version of Build Back Better, the bill also has cost-hiding gimmicks. Take the ObamaCare subsidies that the American Rescue Plan extended for a year. The new bill would extend them for three more years, though Democrats almost certainly intend them to be permanent. This “temporary” extension allows Democrats to pretend this measure would cost only $65 billion, concealing the $155 billion the expansion would cost for the rest of the decade. Voters didn’t like this hocus-pocus when Democrats tried it last year, and now they’ve also seen what unnecessary spending does to inflation.

The bill is also likely to harm growth with its $470 billion in revenue increases via new taxation. As Republicans will surely note again and again, that’s the last thing Washington should be doing during a recession. And so much for Mr. Biden’s promise never to raise taxes on families making less than $400,000. Analysis from the Joint Tax Committee says taxes on families making less than $100,000 a year will rise by $5.8 billion in 2023 and taxes on those making less than $500,000 a year will jump by $30.8 billion.

By Karl Rove

Read Full Article on WSJ.com

Contact Your Elected Officials
The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

NFL’s Bad Bunny had Fans Running

NFL and NBC lost viewers for about 30 minutes on Big Game Sunday as fans ditched network TV for TPUSA’s All-American Halftime Show online.

Senior Voters Are Key For GOP Victory In Midterms

Seniors are the most reliable voting bloc and could decide 2026. To win, the GOP must prevent major Medicare Advantage cost hikes for seniors.

Post-Epstein Document Dump: The Moment for Left-Right Populist Unity?

Claims that a powerful, lawless network of child abusers has captured major Western institutions are now asserted with unprecedented certainty.

When care leads to death

On December 12, Illinois legalize physician assisted suicide, rebranded under the soothing sounding banner of “medical aid in dying,” or MAID.

Two Big Game Halftime Show Options

During the Super Bowl this year there will be two halftime shows going on at the same time competing for viewers.

California Sues Companies for Supporting Ghost Gun Manufacturing

California AG Rob Bonta sued two companies and over 100 individuals, alleging they illegally distributed computer code used to 3D-print ghost guns.

‘All-American Halftime Show’ Serves as Alternative to Super Bowl’s Bad Bunny, Green Day Performance

Dueling halftime performances will vie for the attention of viewers across the world at Super Bowl LX in Santa Clara, California, on Sunday night.

Pentagon to Cut Academic Ties With Harvard, Hegseth Says

Secretary of War Pete Hegseth said the Pentagon will cut all academic ties with Harvard, saying the university no longer meets military services needs.

Appeals Court Rejects Challenge to Trump’s Orders Curbing DEI

A federal appeals court turned away a challenge to President Trump’s EO ending so-called DEI programs in the federal government.

Why Canada’s China Pivot Makes US Tariff Relief Harder

Analysts say Ottawa’s Beijing outreach is raising new security and trade concerns in Washington—making U.S. tariff relief even harder to secure.

Trump Lifts Biden-Era Restrictions on Commercial Fishing in Atlantic Marine Monument

President Trump revoked a prohibition on commercial fishing in the Northeast Canyons and Seamounts Marine National Monument.

US Unveils Interim Trade Framework With India, Drops Punitive Tariff

“The Interim trade framework between the US and India will represent a historic milestone in our countries’ partnership" countries said in a joint statement.

Trump Says He’s Still Looking ‘Seriously’ at Sending $2,000 Tariff Rebate Payments

Trump said in an interview that his administration is still considering sending out $2,000 payments to Americans derived from his tariffs.
spot_img

Related Articles